(12) International Application Status Report

Received at International Bureau: 03 March 2013 (03.03.2013)

Information valid as of: 12 January 2015 (12.01.2015)

Report generated on: 25 March 2019 (25.03.2019)

(10) Publication number: (43) Publication date: (26) Publication language:
WO 2013/09363727 June 2013 (27.06.2013) English (EN)

(21) Application number: (22) Filing date: (25) Filing language:
PCT/IB2012/00304519 December 2012 (19.12.2012) English (EN)

(31) Priority number(s): (32) Priority date(s): (33) Priority status:
61/577,279 (US)19 December 2011 (19.12.2011) Priority document received (in compliance with PCT Rule 17.1)

(51) International Patent Classification:
C12N 15/82 (2006.01); A01H 5/00 (2006.01); C07K 14/415 (2006.01); C12N 9/16 (2006.01); C12N 9/78 (2006.01)

(71) Applicant(s):
SZKOLA GLOWNA GOSPODARSTWA WEIJSKIEGO W WARSZAWIE [PL/PL]; Ul. Nowoursynowska 166 PL-02-787 Warszawa (PL) (for all designated states)
KARPINSKI, Stanislaw [PL/PL]; Ul. Nowoursynowska 166 PL-02-787 Warszawa (PL) (for all designated states)
SZECHYNSKA-HEBDA, Magdalena [PL/PL]; Ul. Nowoursynowska 166 PL-02-787 Warszawa (PL) (for all designated states)
SLESAK, Ireneusz [PL/PL]; Ul. Nowoursynowska 166 PL-02-787 Warszawa (PL) (for all designated states)
WITUSZYNSKA, Weronika [PL/PL]; Ul. Nowoursynowska 166 PL-02-787 Warszawa (PL) (for all designated states)

(72) Inventor(s):
KARPINSKI, Stanislaw; Ul. Nowoursynowska 166 PL-02-787 Warszawa (PL)
SZECHYNSKA-HEBDA, Magdalena; Ul. Nowoursynowska 166 PL-02-787 Warszawa (PL)
SLESAK, Ireneusz; Ul. Nowoursynowska 166 PL-02-787 Warszawa (PL)
WITUSZYNSKA, Weronika; Ul. Nowoursynowska 166 PL-02-787 Warszawa (PL)

(74) Agent(s):
IP21 LIMITED; Central Formalities Department Lakeside 300 Old Chapel Way Broadland Business Park Norwich NR7 0WG (GB)

(54) Title (EN): PLANT TREATMENT METHODS AND MEANS THEREFOR
(54) Title (FR): PROCÉDÉS DE TRAITEMENTS DES PLANTES ET MOYENS ASSOCIÉS

(57) Abstract:
(EN): A transgenic plant having a gene construct including a nucleotide sequence including least two of phytoalexin deficient 4 (PAD4) gene, lesion simulating disease 1 (LSD1 ) gene, and enhanced disease susceptibility 1 (EDS1 ) gene and a method of regulating growth and increasing biomass production in the plant by over expressing or attenuating the expression of at least two of PAD4 gene, LSD1 gene, and EDS1 gene in the plant is provided. The transgenic plant exhibits increased biomass, increased stress tolerance, efficient growth development, greater fruit or seed yield, and/or efficient use of water or early appearance of fruit or seed than a non- transgenic plant that does not overexpress or attenuate at least two of PAD4 LSD1, and EDS1 genes, when the transgenic plant and the non-transgenic plant are cultivated under identical growth conditions and identical stress conditions.
(FR): L'invention concerne une plante transgénique ayant une construction de gène incluant une séquence de nucléotides incluant au moins deux parmi le gène 4 déficient en phytoalexine (PAD4), le gène 1 de la maladie simulant une lésion (LSD1), et le gène 1 de sensibilité accrue à la maladie (EDS1) et un procédé de régulation de la croissance et d'augmentation de la production de la biomasse chez la plante par surexpression ou atténuation de l'expression d'au moins deux parmi le gène PAD4, le gène LSD1, et le gène EDS1 dans la plante. La plante transgénique montre une biomasse accrue, une tolérance au stress accrue, un développement de croissance efficace, un rendement en fruit et graines plus grand et/ou une utilisation efficace de l'eau ou une apparition précoce des fruits ou des graines par rapport à une plante non transgénique qui ne surexprime pas ou n'atténue pas au moins deux parmi les gènes PAD4, LSD1, et EDS1, quand la plante transgénique et la plante non transgénique sont cultivées sous des conditions de croissance identiques et des conditions de stress identiques.

International search report:
Received at International Bureau: 22 July 2013 (22.07.2013) [EP]

International Report on Patentability (IPRP) Chapter II of the PCT:
Chapter II demand received: 18 October 2013 (18.10.2013)

(81) Designated States:
AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
European Patent Office (EPO) : AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
African Intellectual Property Organization (OAPI) : BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG
African Regional Intellectual Property Organization (ARIPO) : BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW
Eurasian Patent Organization (EAPO) : AM, AZ, BY, KG, KZ, RU, TJ, TM